Simvastatin reduces forearm vascular responsiveness to norepinephrine.
Abbott
D
D
Daher
A
A
Manwaring
P
P
Howes
L G
LG
D000924:Anticholesteremic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001916:Brachial Artery / Q000187:drug effects / Q000503:physiopathology; D002784:Cholesterol / Q000097:blood; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology; D005500:Follow-Up Studies; D005542:Forearm / Q000098:blood supply*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000494:pharmacology*; D019821:Simvastatin; D014661:Vasoconstriction / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D000924:Anticholesteremic Agents; D014662:Vasoconstrictor Agents; D002784:Cholesterol; D008148:Lovastatin; D019821:Simvastatin; D009638:Norepinephrine